Columbus Memory Center, PC

Columbus, Georgia 31909

0 studies enrolling now · 6 studies all time

What they study most

Alzheimer Disease, Alzheimer Disease (AD), Alzheimer's Disease, Mild Cognitive Impairment (MCI)

Studies at this site

• A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1) — Completed
• A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease — Running, not enrolling
• Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease — Stopped early
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early
• A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4) — Completed
• A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease — Completed